<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To examine the relationship between the severity of depressive symptoms and the burden through <z:mp ids='MP_0002055'>diabetes</z:mp> care, or diagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, irrespective of the <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> and glycemic control </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: Subjects were 126 outpatients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> who completed the Beck <z:hpo ids='HP_0000716'>Depression</z:hpo> Inventory-II (BDI-II), Problem Areas in <z:mp ids='MP_0002055'>Diabetes</z:mp> (PAID) scale, and Short Form-36 (SF-36) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The factor with a significant impact on the BDI-II score in the multiple regression model was the PAID score (standardized coefficient =0.17, 95% confidence interval [CI], 0.12-0.21) </plain></SENT>
<SENT sid="3" pm="."><plain>The factors having a significant impact on the physical component summary of SF-36 (PCS) in the multiple regression model were BDI-II score (-0.95; 95% CI, -1.32 - -0.58), age (-0.43; 95% CI, -0.61 - -0.25), and the number of complicated <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathies</z:e> (-8.90; 95% CI, -12.71 - -5.08) </plain></SENT>
<SENT sid="4" pm="."><plain>The factors with a significant impact on the mental component summary of SF-36 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCS</z:e>) in the multiple regression model were BDI-II score (-0.90; 95% CI, -1.16 - -0.65) and age (0.13; 95% CI, 0.00-0.25) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: These findings show that <z:mp ids='MP_0002055'>diabetes</z:mp>-related <z:e sem="disease" ids="C0700361" disease_type="Mental or Behavioral Dysfunction" abbrv="">emotional distress</z:e> is significantly related to the severity of depressive symptoms in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, independent of the severity of complications and glycemic control </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, the severity of depressive symptoms is negatively correlated with comprehensive health-related QOL in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Clinicians need to consider factors other than indices of metabolic control and <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e>, in determining the adverse effects of depressive symptoms on the physical QOL of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>